Lenticular changes in eyes with advanced intraocular retinoblastoma: A histopathological study of 48 enucleated eyes.


Journal

Seminars in ophthalmology
ISSN: 1744-5205
Titre abrégé: Semin Ophthalmol
Pays: England
ID NLM: 8610759

Informations de publication

Date de publication:
19 May 2022
Historique:
pubmed: 13 8 2021
medline: 15 6 2022
entrez: 12 8 2021
Statut: ppublish

Résumé

To evaluate the lenticular changes in advanced intraocular retinoblastoma (RB) and identify the risk factors for cataract in these eyes. Retrospective analysis of 48 primary enucleations. All enucleated eyes were classified either as group D (n = 7; 15%) or group E (n = 41; 85%) tumors based on the International Classification of Intraocular Retinoblastoma. Of the 48 enucleated eyes with RB, cataract was noted clinically in only 5 (18%) cases, while histopathology revealed cataractous changes in 28 (58%) cases. Based on histopathology, the cataractous changes included anterior subcapsular cataract ( Eyes with advanced RB can harbor cataract in 58% cases, though most of these are subclinical. Clinically significant cataract may be evident in only 18% cases. Increased tumor necrosis is associated with the development of cataractous changes in RB cases.

Identifiants

pubmed: 34383612
doi: 10.1080/08820538.2021.1962367
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

480-484

Auteurs

Saumya Jakati (S)

Ophthalmic Pathology Laboratory (SJ, DKM), L V Prasad Eye Institute, Hyderabad, India.

Vijitha S Vempuluru (VS)

The Operation Eyesight Universal Institute for Eye Cancer (VSV, SK), L V Prasad Eye Institute, Hyderabad, India.

Ashik Mohamed (A)

Ophthalmic Biophysics (AM), L V Prasad Eye Institute, Hyderabad, India.

Dilip K Mishra (DK)

Ophthalmic Pathology Laboratory (SJ, DKM), L V Prasad Eye Institute, Hyderabad, India.

Swathi Kaliki (S)

The Operation Eyesight Universal Institute for Eye Cancer (VSV, SK), L V Prasad Eye Institute, Hyderabad, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH